condition	mean	min	max
GCGS0457,reduced ceftriaxone suscept	2926.0733333333333	1797.39	3606.65
FA1090/H041,60min+PMN	2512.5644444444447	2063.64	3098.96
FA1090,L-log,from bact	7570.3975	7186.74	7998.38
GCGS1095,reduced ceftriaxone suscept	3746.434	3480.25	4049.25
from N. gon mtr mut mosiac transformant	1815.9533333333334	997.99	3250.54
WT,from L-log cell cultures	4459.294	3064.07	7666.36
from lab,SP319,reduced ceftriaxone suscept	3815.932	3441.76	4432.44
FA1090/H041,0min+PMN	2156.8038461538463	1317.84	4017.28
from lab,SP316,reduced ceftriaxone suscept	2892.935	2628.48	3157.39
FA1090cpxR::erm,L-log,from bact	3658.215	3524.33	3912.26
FA1090 GCM77,strain+mut,untreated	199.09866666666667	146.216	235.803
GCGS1014,reduced ceftriaxone suscept	3282.0975	2895.46	3464.83
from urethra,test for azithromycin resist	341.983	312.387	364.715
FA1090/H041,60min	1293.2678461538462	825.361	1667.63
WT parent,FA19 WT,from p-log cells	1730.029	993.007	2142.15
WT,FA19,from p-L-log cells	5177.7	3876.38	7666.35
overexp mtrCDE,FA19,from p-L-log cells	3381.665	3064.07	3699.26
FA1090 GCM77,strain+mut,H2O2	140.63299999999998	122.692	161.146
FA1090cpxA::kan,L-log,from bact	7933.33	6332.05	8861.52
from p-cells	1816.74	1816.74	1816.74